譚海寧

譚海寧

譚海寧,1983年生,山東淄博人,博士,山東大學教授,博士生導師,國家糖工程技術研究中心副主任,山東省泰山產業領軍人才。主要從事生物藥物、抗腫瘤藥物和醫養健康產品研發。2009年畢業於山東大學藥學院獲醫學博士學位,現工作于山東大學國家糖工程技術研究中心。

基本介紹

  • 中文名:譚海寧
  • 出生日期:1983年
  • 學位/學歷:博士
  • 籍貫:山東淄博
人物經歷,研究方向,代表性論文,

人物經歷

1983年出生於山東省淄博市,2004年本科畢業於山東大學藥學院,獲醫學學士學位,2009年畢業於山東大學藥學院獲醫學博士學位。主要從事蛋白質、多肽、糖等生物藥物先後主持國家自然科學基金和山東省重點研發計畫等國家級和省部級項目十餘項,橫向課題數項;先後主持國家級、省部級及橫向課題十餘項,作為課題副組長完成民口和軍口國家重大新藥創製計畫各1項;在Small, Journal of Controlled Release和Carbohydrate Polymers等學術期刊上發表SCI論文30餘篇;獲得發明專利數項;參編著作數部;Acs Nano和Carbohydrate Polymers等學術期刊審稿人;Current Phamaceutical Biotechnology等雜誌客座編輯;中國生物化學與分子生物學會工業生物化學與分子生物學會分會理事,中國藥理學會海洋藥物藥理專業委員會委員。

研究方向

生物藥物。

代表性論文

1. Feng Sun, Huiwen Hou, Yan Li, Wen Tang, Jie Wang, Lu Lu, Jiaai Fu, Zengmei Liu, Didi Gao, Feiyan Zhao, Xinqing Gao, Peixue Ling, Fengshan Wang, and Haining Tan*. Glycol-split Heparin-Linked Prodrug Nanoparticles Target the Mitochondrion Apparatus for Cancer Metastasis Treatment, Small, 2023, 2206491.
2. Yan Li, Huiwen Hou, Zengmei Liu, Wen Tang, Jie Wang, Lu Lu, Jiaai Fu, Didi Gao, Feiyan Zhao, XinQing Gao, Peixue Ling, Fengshan Wang, Feng Sun, and Haining Tan*. CD44 targeting nanodrug based on chondroitin sulfate for melanoma therapy by inducing mitochondrial apoptosis pathways. Carbohydrate Polymers, 2023, 320, 121255.
3. Feng Sun, Zhendong Wang, Zhifang Yang, Yan Li, Huifei Cui, Chunhui Liu, DezongGao, Fengshan Wang, and Haining Tan*. Characterization, bioactivity and pharmacokinetic study of a novel carbohydrate-peptide polymer: glycol-split heparin-endostatin2 (GSHP-ES2). Carbohydrate Polymers, 207, 79-90, 2019.
4. Zhendong Wang, Yan Li, Liang Xing, Feng Sun, Zhifang Yang, Fengshan Wang, and Haining Tan*. Effects of the anti-angiogenic carbohydrate-peptide conjugate, chitooligosaccharide-ES2 on endothelial cells and tumor-bearing mice. Carbohydrate Polymers, 208, 302-313, 2019.
5. Feng Sun, Yang Yu, Zhifang Yang, Zhendong Wang, Yan Li, Fengshan Wang, and Haining Tan*. Hyaluronic acid-endostatin2-alft1 (HA-ES2-AF) nanoparticle-like conjugate for the target treatment of diseases. Journal of Controlled Release, 288,1-13, 2018.
6. Yang Yu, Feng Sun, Congcong Zhang, Zhendong Wang, Jinfeng Liu, and Haining Tan*. Study on glyco-modification of endostatin-derived synthetic peptide endostatin2 (ES2) by soluble chitooligosaccharide. Carbohydrate Polymers, 154, 204-213, 2016.
7. Zhongying Gong, Baolong Zhou, Xiaoying Liu, Juanjuan Cao, Zexin Hong, Jingye Wang, Xirui Sun, Xiaomeng Yuan, Haining Tan*, Hongjie Ji, and Jingkun Bai* Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy. ACS Appl Mater Interfaces, 13, 47, 55

相關詞條

熱門詞條

聯絡我們